Drug to help cancer children down under

A drug developed by a Leicestershire company will help hundreds of children suffering from cancer in Australia

Singapore: Two months after Leicestershire company Nova Laboratories received US approval to sell Xaluprine in the country, it has now decided to head down under. The company received permission to market the drug in Australia by the Therapeutic Goods Administration after working in partnership with LINK Healthcare, based in Australia. The company said in an official statement that the drug will be sold in Australia as ALLMERCAP. The company will be helping hundreds of children suffering from cancer in Australia as it expects to supply the country with thousands of the 100ml bottles of the liquid drug each year. Nova had already announced that the US success would help it double production of the drug at its Gloucester Crescent plant and create 60 jobs at the site over the next five years.

See more at: http://www.biospectrumasia.com/biospectrum/regulatory/217647/drug-help-cancer-children#sthash.kflw17VS.dpufRead more at: http://www.biospectrumasia.com/biospectrum/regulatory/217647/drug-help-cancer-children

and here: http://www.en-cphi.cn/news/show-19173.html


Download all our latest product lists, this months Newsletter and news articles from Nova Laboratories.


Career Opportunities

We welcome speculative enquiries and applications from anyone with experience in the pharmaceutical industry, the right attitude and relevant qualifications.

Know More

Contact Us

For all product enquires, please contact our customer services team on 0800 975 48 40 or alternatively you can email us at [email protected]